Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress

PartnershippositivePositive

AI Analysis

Summary

Nxera Pharma will receive an $8.6 million milestone payment from Centessa Pharmaceuticals (an Eli Lilly subsidiary) following achievement of a late-stage development milestone for a selective orexin receptor 2 agonist portfolio. The payment will be recognized as revenue in Q3 2026.

Financial Highlights

Revenue

$8.6 million

Outcome Details

Late-stage development milestone achieved, triggering $8.6 million payment

Importance:5/10

Sentiment:

0.60

milestone paymentresearch collaborationlate-stage developmentorexin receptor agonist

Related Companies

$LLY

Read the original article

Published by GlobeNewswire Clinical Studies on September 3, 2026 6:34 AM

Read Original